Publicar

RASTREAMENTO E TERAPIAS PERSONALIZADAS NO CÂNCER DE PULMÃO: AVANÇOS E IMPACTO NA SOBREVIDA

Doi: 10.47094/978-65-284-0234-2/40

PALAVRAS CHAVE: Câncer de pulmão. Rastreamento de adenocarcinoma. Terapiasalvo. Imunoterapia.

KEYWORDS: Lung cancer. Adenocarcinoma screening. Targeted therapies. Immunotherapy.

ABSTRACT:
INTRODUCTION: Lung cancer, especially adenocarcinoma, is the leading cause of cancer death worldwide. Although smoking is the main risk factor, the incidence is increasing in non-smokers. In recent years, there have been significant advances in the treatment of non-small cell lung cancer, with a reduction in mortality, driven by targeted therapies and immunotherapies for specific mutations. OBJECTIVES: To evaluate evidence on innovative lung cancer screening and treatments and their impact on survival.

Autores

  • Ernandes da Silva Filho

  • Ester Emanuela Mariano

  • Marcos Vinícius Ribeiro Alves Trindade

  • Mariana Melo Pereira

Download